Connect Biopharma ( NASDAQ: CNTB ) said on Wednesday it had appointed Barry Quart as chief executive officer. Former chief executive officer Zheng Wei will remain on the board of directors and serve as an advisor to assist with the transition. The company also appointed David Szekeres as president.
Kleanthis Xanthopoulos was appointed as chair of the board of directors. Press release More on Connect Biopharma Pfizer-Connect Biopharma deal for anti-inflammatory agent ends Seeking Alpha’s Quant Rating on Connect Biopharma Historical earnings data for Connect Biopharma Financial information for Connect Biopharma.
